Our data may provide insight into two extant questions: 1) whether monocytes/macrophages can selectively home to a pathological brain region without disruption of the BBB; and 2) whether this alternative approach offers a viable therapeutic strategy in light of the reported failures of focal GDNF delivery for Parkinson’s disease. This evidence concerns the gene GDNF and Parkinson disease.